|
Zantac 25Drug - Zantac 25 The trade name of the product as shown on the labeling.
Dosage -
TABLET, EFFERVESCENT; ORAL
Active Ingredient(s) -
Ranitidine Hydrochloride
Strength -
EQ 25MG BASE
Applicant -
GLAXOSMITHKLINE
New Drug Application (NDA) Number -
020251
Product Number -
003
Therapeutic Equivalence (TE) Code -
Approval Date -
Apr 1, 2004
Reference Listed Drug (RLD) -
No
Type -
RX
Applicant Full Name -
Glaxosmithkline
Zantac 25
Zantac Eq 15mg Base/ml Syrup; Oral
Zantac 150 Eq 150mg Base Tablet, Effervescent; Oral Zantac 25 Eq 25mg Base Tablet, Effervescent; Oral Zantac 300 Eq 300mg Base Capsule; Oral Zantac 150 Eq 150mg Base/packet Granule, Effervescent; Oral Ranitidine Eq 25mg Base/ml Injectable; Injection Ranitidine Hcl Eq 25mg Base/ml Injectable; Injection Zantac Eq 25mg Base/ml Injectable; Injection Zantac In Plastic Container Eq 1mg Base/ml Injectable; Injection Zantac In Plastic Container Eq 50mg Base/100ml Injectable; Injection NewDrugInformation |